In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects
2006

Effects of MLH1 and MSH2 Mutations on Splicing

Sample size: 99 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lastella Patrizia, Surdo Nicoletta Concetta, Resta Nicoletta, Guanti Ginevra, Stella Alessandro

Primary Institution: University of Bari, Italy

Hypothesis

How do predictions from in silico analysis correlate with in vivo splicing results for MLH1 and MSH2 missense mutations?

Conclusion

The study found that algorithms predicting splicing effects do not always align with actual splicing outcomes, indicating the need for caution in mutation pathogenicity assessments.

Supporting Evidence

  • Eight out of twenty mutations caused significant changes in splicing patterns.
  • Six mutations led to a decrease of at least 50% in exon inclusion compared to wild type.
  • Predictions from PESX correlated better with splicing behavior than those from other algorithms.

Takeaway

Some changes in genes can make it harder for cells to correctly read the instructions for making proteins, but figuring out which changes matter is tricky.

Methodology

The study analyzed 99 missense mutations using six algorithms and tested 20 mutations in three different cell lines to assess splicing effects.

Potential Biases

Potential bias in the interpretation of algorithm predictions versus experimental results.

Limitations

The predictions from algorithms do not always correlate with actual splicing outcomes, especially in well-defined exons.

Participant Demographics

Not specified.

Statistical Information

P-Value

0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-7-243

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication